Chemical Formula: C21H25ClN2O2

Chemical Formula C21H25ClN2O2

Found 14 metabolite its formula value is C21H25ClN2O2

DGR7D6J5TR

methyl (1R,12R,19S)-12-ethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,9,13-pentaene-10-carboxylate;hydrochloride

C21H25ClN2O2 (372.160446)

1-PYRROLIDIN-2-(2-CHLOROPHENYL)-2-(N-CBZ-N-METHYL)AMINO-ETHANE

C21H25ClN2O2 (372.160446)

1-PYRROLIDIN-2-(3-CHLOROPHENYL)-2-(N-CBZ-N-METHYL)AMINO-ETHANE

C21H25ClN2O2 (372.160446)

3H-Indolium,2-[2-[(2,4-dimethoxyphenyl)amino]ethenyl]-1,3,3-trimethyl-, chloride (1:1)

C21H25ClN2O2 (372.160446)

LY-272015 hydrochloride is an orally active, specific 5-HT2B receptor antagonist. LY-272015 hydrochloride completely inhibits the phosphorylation of ERK2 induced by 5-HT or BW723C86. LY-272015 hydrochloride is antihypertensive in Deoxycorticosterone Acetate (DOCA)-salt-hypertensive rats[1][2].

(9H-Fluoren-9-yl)methyl 4-(aminomethyl)piperidine-1-carboxylate hydrochloride

C21H25ClN2O2 (372.160446)

CBL0137 (hydrochloride)

C21H25ClN2O2 (372.160446)

CBL0137 hydrochloride is an inhibitor of the histone chaperone, FACT. CBL0137 hydrochloride can also activate p53 and inhibits NF-κB with EC50s of 0.37 and 0.47 μM, respectively.

n-[(6r,7r,8r,8ar,10as)-6-chloro-7-ethenyl-7,10,10-trimethyl-8-(methylideneamino)-9-oxo-6,8,8a,10a-tetrahydro-5h-anthracen-1-yl]carboximidic acid

C21H25ClN2O2 (372.160446)

n-[(6r,7r,8r,8as,10ar)-6-chloro-7-ethenyl-7,10,10-trimethyl-8-(methylideneamino)-9-oxo-6,8,8a,10a-tetrahydro-5h-anthracen-1-yl]carboximidic acid

C21H25ClN2O2 (372.160446)

n-[6-chloro-7-ethenyl-7,10,10-trimethyl-8-(methylideneamino)-9-oxo-6,8,8a,10a-tetrahydro-5h-anthracen-1-yl]carboximidic acid

C21H25ClN2O2 (372.160446)

Chemical Formula: C21H25ClN2O2